Schedule 13D ownership disclosure

LIPELLA PHARMACEUTICALS INC.

Common Stock, par value $0.0001 per share · CUSIP: 53630L209

Event date: 2025-02-06

Filing-level shares
209,640.00
Percent of class
7.9%
  • Michael B. ChancellorReported CIK 0001959360

    Shares: 209,640.00 · Class: 7.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-25-000200
Form type
SCHEDULE 13D/A
Filer
Chancellor Michael B
CIK
CIK 1959360
Filed
Feb 10, 2025
Reporting period
Feb 06, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub